Provided by Tiger Trade Technology Pte. Ltd.

Park Hotels & Resorts Inc.

10.80
+0.19501.84%
Volume:128.24K
Turnover:1.38M
Market Cap:2.17B
PE:-7.55
High:10.82
Open:10.58
Low:10.58
Close:10.60
52wk High:12.39
52wk Low:8.27
Shares:201.40M
Float Shares:195.63M
Volume Ratio:0.71
T/O Rate:0.07%
Dividend:1.00
Dividend Rate:9.26%
EPS(TTM):-1.4300
EPS(LYR):-1.4300
ROE:-8.31%
ROA:2.12%
PB:0.69
PE(LYR):-7.55

Loading ...

Evercore ISI Keeps Their Hold Rating on Park Hotels & Resorts (PK)

TIPRANKS
·
Oct 31, 2025

Park Hotels & Resorts Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
Oct 31, 2025

Park Hotels & Resorts posts $14 million net loss in Q3 2025

Reuters
·
Oct 31, 2025

BRIEF-Park Hotels & Resorts Q3 Adjusted FFO Per Share USD 0.35

Reuters
·
Oct 31, 2025

Park Hotels & Resorts Q3 Adjusted Ffo per Share USD 0.35

THOMSON REUTERS
·
Oct 31, 2025

Park Hotels & Resorts Inc. Reports Third Quarter 2025 Results

THOMSON REUTERS
·
Oct 31, 2025

Celldex Announces Initial Positive Results from Phase 1 Trial of CDX-622 Demonstrating Favorable Safety and PK Profile and Sustained Mast Cell Inhibition

GlobeNewswire
·
Oct 31, 2025

Forte Minerals Corp. to Present at New Orleans Investment Conference

Reuters
·
Oct 30, 2025

Emperor Metals Inc. to Showcase Growth at New Orleans Investment Conference

Reuters
·
Oct 30, 2025

Latest Data of InnoCare's Zurletrectinib Orally Presented at SIOP 2025

GlobeNewswire
·
Oct 30, 2025

Amarc Resources Ltd. to Attend New Orleans Investment Conference

Reuters
·
Oct 29, 2025

Comstock Mining Inc. to Sponsor and Present at New Orleans Investment Conference

Reuters
·
Oct 29, 2025

Park Hotels & Resorts Inc expected to post earnings of 3 cents a share - Earnings Preview

Reuters
·
Oct 29, 2025

Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance

GlobeNewswire
·
Oct 29, 2025

Antengene Presents Latest Preclinical Data of ATG-201 (CD19 x CD3 TCE) at ACR 2025

prnewswire
·
Oct 27, 2025

Creative Management Flourishing! “Youth Shop” Owners Compete in Vocational Skills

Deep News
·
Oct 25, 2025

Jinbo vs. Juzhi: Li Jiaqi's Live Stream Room "Changes Roles", Collagen Leaders Engage in Undercover Competition in C-End Beauty

Deep News
·
Oct 25, 2025

Denifanstat Achieved All Endpoints in the Treatment of Moderate to Severe Acne in Phase 3 Clinical Trial in Acne in China: A Presentation at the 2025 Fall Clinical Dermatology Conference

GlobeNewswire
·
Oct 24, 2025

ProMIS Neurosciences Strengthens Board with Appointment of Slanix Paul Alex, Pharm.D., President and Portfolio Manager, Public Equity of Ally Bridge Group

GlobeNewswire
·
Oct 22, 2025

CERo Therapeutics Announces Third Dose for Patient in Phase 1 Clinical Trial of CER-1236 in AML

GlobeNewswire
·
Oct 21, 2025